Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Media
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
  • e3
  • Concept Fund
  • iMCI
  • Portfolio
  • ACT Tulsa
  • Contact

News

Falling in love with eye research

By sarah | News | 0 comment | 17 November, 2019 | 0

By Scott Meacham When Younghwa “Henry” Shin, Ph.D., a co-founder and CEO of Excitant Therapeutics entered graduate school at the University of Oklahoma Health Sciences Center (OUHSC), his interest was neuroscience. Then, during a year of rotation structured to give students a taste of different projects and specialties, he was assigned to Dr. Jian-Xing (Jay)Read more

Worth the wait: UCO scientist Chen pioneers new approach to cancer treatment

By sarah | News | 0 comment | 1 December, 2017 | 0

 By Jim Stafford Copyright © 2017, The Oklahoma Publishing Co. When an email from the National Institutes of Health (NIH) landed in his inbox on the eve of Spring break last March, Wei R. Chen, Ph.D., refused to open it. He read the subject line, which told him that the score of his NIH R01Read more

Ultra Botanica pioneers use of curcumin as dietary supplement

By admin | News | Comments are Closed | 14 June, 2016 | 0

Curcumin is the most active ingredient in a plant called Turmeric, which grows wild in Asian countries and is ground into a powder and used as a spice in cooking. Curcumin has been shown to provide potent antioxidant and anti-inflammatory benefits to humans. Decades ago, scientists began to notice that the folks who had a lot of Tumeric in their diet showed lower rates of Alzheimer’s disease, and prostate and pancreatic cancers.

Innovation & Entrpreneurs: Serial entrepreneurs launch own diagnostics-focused company in state

By admin | News | 0 comment | 23 February, 2016 | 0

I get really excited when I see an Oklahoma startup improving the lives of people who have incurable debilitating disease. That’s the story of Progentec Diagnostics, a startup that is focused on developing breakthrough diagnostics. The firm’s initial focus is on developing a diagnostic test to identify patients at increased risk for flare in lupus, an incurable autoimmune disease that afflicts 1.5 million patients in the U.S.

Outlook for city’s bioscience sector remains strong in 2016

By sarah | News | Comments are Closed | 4 January, 2016 | 0

For the sake of Oklahoma’s energy sector, let’s hope the New Year brings a bump in oil and gas prices. But even if that doesn’t happen, there are still plenty of economic silver linings to be found in the state.

Forum to weigh research funding’s benefits

By admin | Uncategorized | Comments are Closed | 13 October, 2015 | 0

Oklahoma science, technology forum to weigh research funding’s benefits By Jim Stafford Copyright © 2015 The Oklahoma Publishing Co. The journey from discovery in a research laboratory to commercial use of a new drug is filled with obstacles, setbacks and the certainty that millions of dollars will be required to advance it against long odds.Read more

Oklahoma’s life science startup companies take a different route

By admin | Entrepreneur, News | Comments are Closed | 1 September, 2015 | 0

It’s not always apparent just how significant Oklahoma’s opportunity in life science startup companies is.

When we talk about startups, we tend toward information technology or advanced manufacturing deals. Things move faster in those types of businesses. Solutions are easier to understand. There’s simply more to talk about from week to week.

i2E-300dpi-Trans-Light
  • Events
  • News
  • Resources
  • Media
  • Love’s Cup

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
PHONE 405/235-2305
Click HERE for printable map with directions.

Tulsa Office

100 S. Cincinnati Ave – 5th Floor, Suite 514
Tulsa, OK 74103
PHONE 918/582-5592
Copyright 2022 i2E, Inc. | All Rights Reserved
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
    • ACT Tulsa
  • e3
  • Concept Fund
  • Portfolio
  • iMCI
  • ACT Tulsa
  • Contact
i2E